Letrazole(Femara)

Keywords：Letrozole,FEMARA,LETROZOL,LETRAZOLE,Lelrozol , 112809-51-5, letrozolex

Product name: Letrozole

CAS: 112809-51-5

MF: C17H11N5

MW: 285.3

Description: Letrozole (INN, trade name Femara) is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.

Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.

skype:tracy665      email tracy  at ycphar dot com